Recent policy proposals like 100% drug import tariffs, Most Favored Nation (MFN) pricing, and TrumpRx are sparking conversations across the pharmacy benefits landscape. While the details and eventual impacts of these policies are still unfolding, these developments could potentially influence future pharmacy plans.
Thank you to everyone who was able to join us for “Navigating Pharmacy Policy: Tariffs, MFN Pricing & TrumpRx”. During this session, we reviewed the latest pharmacy policy updates and highlight considerations for brokers and plan sponsors as they monitor for potential impact on their plans.
Learning Objectives:
- Understand the latest policy developments in pharma (proposed pharmaceutical tariffs, Most Favored Nation pricing, TrumpRx)
- Identify potential considerations for plan sponsors and brokers, including PBM contract and pricing implications
About the Speakers:
Erica Waltz, Director of Pharmacy Consulting
Erica Waltz brings over 14 years of experience in the healthcare industry across the public and private sectors. She previously spent eight years at WTW, where she developed pharmacy procurement strategies and delivered strategic pharmacy benefit solutions, with expertise in claims audits, specialty drug analysis, contract oversight, and vendor negotiations. Erica holds a master’s in healthcare administration and is certified in Lean Process Improvement and Mental Health First Aid.
Aya Desouki, PharmD, Clinical Director
Aya Desouki, Clinical Director at Truveris, brings seven years of experience in pharmacy benefit and clinical consulting from BCBS (Florida Blue), Cigna, and Denver Health Medical Plan. She specializes in formulary strategy, drug cost management, and clinical program design. Aya holds a Doctor of Pharmacy from Lipscomb University.
Truveris is a leading digital health company focused on delivering truth and clarity in pharmacy. Truveris’ proprietary technology, coupled with deep pharmacy expertise, helps to build a more efficient market that maximizes choice, accessibility, and prescription drug affordability. Our solutions provide the insight and knowledge to help people lead healthier and more productive lives.
